Publications
The bibliography below contains selected publications produced by members of the EIP Network. It is arranged by topic, with citations listed chronologically.
ABCs and FoodNet Publications
Publications from these surveillance programs are hosted on their respective websites.
ABCs publications: https://www.cdc.gov/abcs/reports-findings/pubs.html
Other Selected EIP Publications, by Topic
Hepatitis
Amon JJ, Devasia R, Xia G et al. Molecular epidemiology of foodborne hepatitis a outbreaks in the United States, 2003. Journal of Infectious Diseases 2005;192(8):1323-1330.
Navarro VJ, St Louis TE, Bell BP. Identification of patients with hepatitis C virus infection in New Haven County primary care practices. Journal of Clinical Gastroenterology 2003;36(5):431-435.
Navarro VJ, St Louis T, Bell BZ, Sofair AN. Chronic liver disease in the primary care practices of Waterbury, Connecticut. Hepatology 2003;38(4):1062.
Trooskin SB, Hadler J, St Louis T, Navarro VJ. Geospatial analysis of hepatitis C in Connecticut: a novel application of a public health tool. Public Health 2005;119(11):1042-1047.
Tugwell BD, Patel PR, Williams IT et al. Transmission of hepatitis C virus to several organ and tissue recipients from an antibody-negative donor. Annals of Internal Medicine 2005;143(9):648-654.
Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 2008;47(4):1128-35.
Tickborne Illness
Centers for Disease Control and Prevention. Statewide surveillance for ehrlichiosis–Connecticut and New York, 1994-1997. MMWR – Morbidity & Mortality Weekly Report 1998; 47(23):476-480.
Chaput EK, Meek JI, Heimer R. Spatial Analysis of Human Granulocytic Ehrlichiosis near Lyme, Connecticut. Emerging Infectious Diseases 2002;8(9):943-948.
Chu FK. Rapid and sensitive PCR-based detection and differentiation of aetiologic agents of human granulocytotropic and monocytotropic ehrlichiosis. Mol Cell Probes 1998;12(2):93-99.
Heimer R, Tisdale D, Dawson JE. A single tissue culture system for the propagation of the agents of the human ehrlichioses. American Journal of Tropical Medicine & Hygiene 1998; 58(6):812-815.
Heimer R, Van Andel A, Wormser GP, Wilson ML. Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes. Journal of Clinical Microbiology 1997;35(4):923-927.
IJdo JW, Meek JI, Cartter ML et al. The emergence of another tickborne infection in the 12-town area around Lyme, Connecticut: human granulocytic ehrlichiosis. Journal of Infectious Diseases 2000;181(4):1388-1393.
IJdo JW, Sun W, Zhang Y, Magnarelli LA, Fikrig E. Cloning of the gene encoding the 44-kilodalton antigen of the agent of human granulocytic ehrlichiosis and characterization of the humoral response. Infection & Immunity 1998;66(7):3264-3269.
IJdo JW, Wu C, Magnarelli LA, Fikrig E. Serodiagnosis of human granulocytic ehrlichiosis by a recombinant HGE-44-based enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 1999;37(11):3540-3544.
IJdo JW, Zhang Y, Hodzic E et al. The early humoral response in human granulocytic ehrlichiosis. Journal of Infectious Diseases 1997;176(3):687-692.
Magnarelli LA, IJdo JW, Anderson JF, Padula SJ, Flavell RA, Fikrig E. Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut. Journal of Clinical Microbiology 1998;36(10):2823-2827.
Magnarelli LA, IJdo JW, Dumler JS, Heimer R, Fikrig E. Reactivity of human sera to different strains of granulocytic ehrlichiae in immunodiagnostic assays. Journal of Infectious Diseases 1998;178(6):1835-1838.
Magnarelli LA, Van Andel AE, IJdo JW, Heimer R, Fikrig E. Serologic testing of horses for granulocytic ehrlichiosis, using indirect fluorescent antibody staining and immunoblot analysis. American Journal of Veterinary Research 1999;60(5):631-635.
Meek JI, Roberts CL, Smith EV, Jr., Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. Journal of Public Health Management & Practice 1996; 2(4):61-65.
Van Andel AE, Magnarelli LA, Heimer R, Wilson ML. Development and duration of antibody response against Ehrlichia equi in horses. J Am Vet Med Assoc 1998;212(12):1910-1914.
Respiratory Disease
Centers for Disease Control and Prevention (CDC). Influenza-testing and antiviral-agent prescribing practices–Connecticut, Minnesota, New Mexico, and New York, 2006-07 influenza season. MMWR – Morbidity & Mortality Weekly Report 2008;57(3):61-5.
Centers for Disease Control and Prevention (CDC). Surveillance for laboratory-confirmed, influenza-associated hospitalizations–Colorado, 2004-05 influenza season. MMWR – Morbidity & Mortality Weekly Report 2005;54(21):535-537.
Grijalva C, Craig A, Dupont W et al. Estimating influenza hospitalizations among children. Emerging Infectious Diseases 2006;12(1):103-109.
Grijalva CG, Weinberg GA, Bennett NM et al. Estimating the undetected burden of influenza hospitalizations in children. Epidemiology & Infection 2007;135(6):951-8.
Louie JK, Hacker JK, Mark J et al. SARS and common viral infections. Emerging Infectious Diseases 2004;10(6):1143-1146.
Louie JK, Schechter R, Honarmand S et al. Severe pediatric influenza in California, 2003-2005: implications for immunization recommendations. Pediatrics 2006;117(4):e610-e618.
Louie JK, Schnurr DP, Guevara HF et al. Creating a model program for influenza surveillance in California: results from the 2005-2006 influenza season. American Journal of Preventive Medicine 2007;33(4):353-7.
Reed C, Angulo FJ, Swerdlow DL, Lipsitch M, Meltzer MI, Jernigan D, et al. Estimates of the prevalence of pandemic (H1N1) 2009, United States, April–July 2009. Emerging Infectious Diseases 2009;15(12):2004-2007.
Schrag SJ, Shay DK, Gershman K et al. Multistate surveillance for laboratory-confirmed, influenza-associated hospitalizations in children: 2003-2004. Pediatric Infectious Disease Journal 2006; 25(5):395-400.
Slavin KA, Passaro DJ, Hacker JK, Hendry RM, Kohl S. Parainfluenza virus type 4: case report and review of the literature. Pediatric Infectious Disease Journal 2000;19(9):893-896.
Talbot TR, Poehling KA, Hartert TV et al. Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. American Journal of Medicine 2005;118(3):285-291.
Syndromic Surveillance
Bakardjiev A, Azimi PH, Ashouri N et al. Amebic encephalitis caused by Balamuthia mandrillaris: report of four cases. Pediatric Infectious Disease Journal 2003;22(5):447-453.
Bakardjiev A, Glaser C, Schuster F, Visvesvara GS. Three-year-old girl with fever and coma. Pediatric Infectious Disease Journal 2002;21(1):75,85-86.
Bloch KC, Schuster FL. Inability to make a premortem diagnosis of Acanthamoeba species infection in a patient with fatal granulomatous amebic encephalitis. Journal of Clinical Microbiology 2005;43(6):3003-3006.
Centers for Disease Control and Prevention (CDC). Severe morbidity and mortality associated with influenza in children and young adults–Michigan, 2003. MMWR Morbidity & Mortality Weekly Report 2003;52(35):837-840.
Centers for Disease Control and Prevention. Suspected brucellosis case prompts investigation of possible bioterrorism-related activity–New Hampshire and Massachusetts, 1999. MMWR Morb Mortal Wkly Rep 2000;49(23):509-512.
Centers for Disease Control and Prevention. Unexplained illness and death among injecting-drug users–Glasgow, Scotland; Dublin, Ireland; and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000;49(22):489-492.
Centers for Disease Control and Prevention (CDC). Update: allograft-associated bacterial infections–United States, 2002. MMWR – Morbidity & Mortality Weekly Report 2002; 51(10):207-210.
Centers for Disease Control and Prevention. Update: Clostridium novyi and unexplained illness among injecting-drug users–Scotland, Ireland, and England, April-June 2000. MMWR Morb Mortal Wkly Rep 2000;49(24):543-545.
Centers for Disease Control and Prevention. Update: Unexplained deaths following knee surgery–Minnesota, 2001. MMWR Morb Mortal Wkly Rep 2001;50(48):1080.
Christie LJ, Honarmand S, Talkington DF et al. Pediatric encephalitis: what is the role of Mycoplasma pneumoniae? Pediatrics 2007;120(2):305-13.
Christie LJ, Honarmand S, Yagi S, Ruiz S, Glaser CA. Anti-galactocerebroside testing in Mycoplasma pneumoniae-associated encephalitis. Journal of Neuroimmunology 2007;189(1-2):129-31.
DeVries A, Lees C, Rainbow J, Lynfield R. Explaining the unexplained: identifying infectious causes of critical illness and death in Minnesota. Minn Med 2008;91(11):34-6.
Dunnebacke TH, Schuster FL, Yagi S, Booton GC. Isolation of Balamuthia amebas from the environment. Journal of Eukaryotic Microbiology 2003;50(Suppl):510-511.
Eldridge BF, Glaser C, Pedrin RE, Chiles RE. The first reported case of California encephalitis in more than 50 years. Emerging Infectious Diseases 2001;7(3):451-452.
Fischer M, Bhatnagar J, Guarner J et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. New England Journal of Medicine 2005; 353(22):2352-2360.
Fowlkes AL, Honarmand S, Glaser C, Yagi S, Schnurr D, Oberste MS, Anderson L, Pallansch MA, Khetsuriani N. Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J Infect Dis 2008;198(11):1685-91.
Francisco AM, Glaser C, Frykman E et al. 2004 California pediatric West Nile virus case series. Pediatric Infectious Disease Journal 2006;25(1):81-84.
Glaser CA, Gilliam S, Schnurr D et al. In search of encephalitis etiologies: diagnostic challenges in the California Encephalitis Project, 1998-2000. Clinical Infectious Diseases 2003;36(6):731-742.
Glaser CA, Honarmand S, Anderson LJ et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clinical Infectious Diseases 2006;43(12):1565-1577.
Guarner J, Sumner J, Paddock CD et al. Diagnosis of invasive group a streptococcal infections by using immunohistochemical and molecular assays. American Journal of Clinical Pathology 2006;126(1):148-155.
Hajjeh RA, Relman D, Cieslak PR et al. Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerging Infectious Diseases 2002;8(2):145-153.
Honarmand S, Glaser CA, Chow E et al. Subacute sclerosing panencephalitis in the differential diagnosis of encephalitis. Neurology 2004;63(8):1489-1493.
Huang C, Campbell W, Grady L, Kirouac I, LaForce FM. Diagnosis of Jamestown Canyon encephalitis by polymerase chain reaction. Clinical Infectious Diseases 1999;28(6):1294-1297.
Huang C, Slater B, Campbell W, Howard J, White D. Detection of arboviral RNA directly from mosquito homogenates by reverse-transcription-polymerase chain reaction. Journal of Virological Methods 2001;94(1-2):121-128.
Huang C, Slater B, Rudd R et al. First Isolation of West Nile virus from a patient with encephalitis in the United States. Emerging Infectious Diseases 2002;8(12):1367-1371.
Huang C, Thompson WH, Karabatsos N, Grady L, Campbell WP. Evidence that fatal human infections with La Crosse virus may be associated with a narrow range of genotypes. Virus Research 1997;48(2):143-148.
Hutchins SS, Sulemana I, Heilpern KL et al. Performance of an algorithm for assessing smallpox risk among patients with rashes that may be confused with smallpox. Clinical Infectious Diseases 2008;46 Suppl 3:S195-203.
Kiang KM, Ogunmodede F, Juni BA et al. Outbreak of osteomyelitis/septic arthritis caused by Kingella kingae among child care center attendees. Pediatrics 2005;116(2):e206-e213.
Kluger MD, Sofair AN, Heye CJ, Meek JI, Sodhi RK, Hadler JL. Retrospective validation of a surveillance system for unexplained illness and death: New Haven County, Connecticut. American Journal of Public Health 2001;91(8):1214-1219.
Lance-Parker S, Rebmann C, Kramer S, Kelly R. Arboviruses in Georgia. Emergence of West Nile Virus. Journal of the Medical Association of Georgia 2002;91(2):32-34.
Lu HZ, Bloch KC, Tang YW. Molecular Techniques in the Diagnosis of Central Nervous System Infections. Curr Infect Dis Rep 2002;4(4):339-350.
Lynch M, Lee B, Azimi P et al. Rotavirus and central nervous system symptoms: cause or contaminant? Case reports and review. Clin Infect Dis 2001;33(7):932-938.
Meek J. West Nile virus in the United States. Current Opinion in Pediatrics 2002;14(1):72-77.
Mullen L, Barry J, Igoe D, Keenan E, Ward M, Murray K. Unexplained illness among injecting drug users in Dublin: a case-control study. Journal of Epidemiology & Community Health 2002;56(8):575-576.
Nikkari S, Lopez FA, Lepp PW et al. Broad-range bacterial detection and the analysis of unexplained death and critical illness. Emerging Infectious Diseases 2002;8(2):188-194.
Park SY, Glaser C, Murray WJ et al. Raccoon roundworm (Baylisascaris procyonis) encephalitis: case report and field investigation. Pediatrics 2000;106(4):E56.
Passaro DJ, Shieh WJ, Hacker JK et al. Predominant kidney involvement in a fatal case of hantavirus pulmonary syndrome caused by Sin Nombre virus. Clin Infect Dis 2001; 33(2):263-264.
Perkins BA, Flood JM, Danila R et al. Unexplained deaths due to possibly infectious causes in the United States: defining the problem and designing surveillance and laboratory approaches. The Unexplained Deaths Working Group. Emerging Infectious Diseases 1996; 2(1):47-53.
Perkins BA, Relman D. Explaining the unexplained in clinical infectious diseases: looking forward. Emerging Infectious Diseases 1998;4(3):395-397.
Price NO, Hacker JK, Silvers JH et al. Adenovirus type 3 viremia in an adult with toxic shock-like syndrome. Clin Infect Dis 2001;33(2):260-262.
Schuster FL, Dunnebacke TH, Booton GC et al. Environmental isolation of Balamuthia mandrillaris associated with a case of amebic encephalitis. Journal of Clinical Microbiology 2003;41(7):3175-3180.
Rainbow J, Lynfield R, Johnson JR, Danila RN. Minnesota surveillance for unexplained deaths and critical illnesses of possible infectious cause. Minnesota Medicine 2000;83(1):51-53.
Rhodes LV, III, Huang C, Sanchez AJ et al. Hantavirus pulmonary syndrome associated with Monongahela virus, Pennsylvania. Emerging Infectious Diseases 2000;6(6):616-621.
Schuster FL, Glaser C, Gilliam S, Visvesvara GS. Survey of sera from encephalitis patients for Balamuthia mandrillaris antibody. Journal of Eukaryotic Microbiology 2001;Suppl:10S-12S.
Schuster FL, Glaser C, Honarmand S, Maguire JH, Visvesvara GS. Balamuthia amebic encephalitis risk, Hispanic Americans. Emerging Infectious Diseases 2004;10(8):1510-1512.
Schuster FL, Honarmand S, Visvesvara GS, Glaser CA. Detection of antibodies against free-living amoebae Balamuthia mandrillaris and Acanthamoeba species in a population of patients with encephalitis. Clinical Infectious Diseases 2006;42(9):1260-1265.
Schuster FL, Yagi S, Gavali S, Michelson D, Raghavan R, Blomquist I, Glastonbury C, Bollen AW, Scharnhorst D, Reed SL, Kuriyama S, Visvesvara GS, Glaser CA. Under the radar: balamuthia amebic encephalitis. Clin Infect Dis 2009;48(7):879-87.
Shepard CW, Daneshvar MI, Kaiser RM et al. Bordetella holmesii bacteremia: a newly recognized clinical entity among asplenic patients. Clinical Infectious Diseases 2004; 38(6):799-804.
Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clinical Infectious Diseases 2002;34(8):1154-1157.
Weinberg A, Bloch KC, Li S, Tang YW, Palmer M, Tyler KL. Dual infections of the central nervous system with Epstein-Barr virus. Journal of Infectious Diseases 2005;191(2):234-237.
Weitkamp JH, Spring MD, Brogan T, Moses H, Bloch KC, Wright PF. Influenza A virus-associated acute necrotizing encephalopathy in the United States. Pediatric Infectious Disease Journal 2004;23(3):259-263.
Yagi S, Booton GC, Visvesvara GS, Schuster FL. Detection of Balamuthia mitochondrial 16S rRNA gene DNA in clinical specimens by PCR. Journal of Clinical Microbiology 2005; 43(7):3192-3197.
Other/General
Begier EM, Barrett NL, Mshar PA, Johnson DG, Hadler JL, Connecticut Bioterrorism Field Epidemiology Response Team. Gram-positive rod surveillance for early anthrax detection. Emerging Infectious Diseases 2005;11(9):1483-1486.
Berkelman RL, Pinner RW, Hughes JM. Addressing emerging microbial threats in the United States. JAMA 1996; 275(4):315-317.
Bryan RT, Pinner RW, Berkelman RL. Emerging infectious diseases in the United States, Improved surveillance, a requisite for prevention. Annals of the New York Academy of Sciences 1994; 740:346-361.
Centers for Disease Control and Prevention. Human rabies–California, Georgia, Minnesota, New York, and Wisconsin, 2000. MMWR – Morbidity & Mortality Weekly Report 2000; 49(49):1111-1115.
Centers for Disease Control and Prevention. Impact of vaccines universally recommended for children–United States, 1990-1998. MMWR – Morbidity & Mortality Weekly Report 1999; 48(12):243-248.
Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine–United States, 1998-1999. MMWR Morb Mortal Wkly Rep 1999; 48(27):577-581.
Centers for Disease Control and Prevention. Surveillance for Creutzfeldt-Jakob disease–United States. MMWR Morb Mortal Wkly Rep 1996; 45(31):665-668.
Cieslak PR, Strausbaugh LJ, Fleming DW, Ling JM. Vancomycin in Oregon: who’s using it and why. Infect Control Hosp Epidemiol 1999; 20(8):557-560.
Colford JM, Jr., Rees JR, Wade TJ et al. Participant blinding and gastrointestinal illness in a randomized, controlled trial of an in-home drinking water intervention. Emerging Infectious Diseases 2002;8(1):29-36.
Colford JM, Jr., Saha SR, Wade TJ et al. A pilot randomized, controlled trial of an in-home drinking water intervention among HIV + persons. Journal of Water & Health 2005; 3(2):173-184.
Colford JM, Jr., Wade TJ, Sandhu SK et al. A randomized, controlled trial of in-home drinking water intervention to reduce gastrointestinal illness. American Journal of Epidemiology 2005;161(5):472-482.
Danila RN, Lexau C, Lynfield R, Moore KA, Osterholm MT. Addressing emerging infections. The partnership between public health and primary care physicians. Postgraduate Medicine 1999; 106(2):90-92.
Eisenberg JN, Wade TJ, Charles S et al. Risk factors in HIV-associated diarrhoeal disease: the role of drinking water, medication and immune status. Epidemiology & Infection 2002; 128(1):73-81.
Eisenberg JN, Wade TJ, Hubbard A et al. Associations between water-treatment methods and diarrhoea in HIV-positive individuals. Epidemiology & Infection 2002;129(2):315-323.
Flannery B, Gelling LB, Vugia DJ et al. Reducing Legionella colonization in water systems with monochloramine. Emerging Infectious Diseases 2006;12(4):588-596.
Friedman MS, Blake PA, Koehler JE, Hutwagner LC, Toomey KE. Factors influencing a communitywide campaign to administer hepatitis A vaccine to men who have sex with men. American Journal of Public Health 2000; 90(12):1942-1946.
Hoffman RE, Greenblatt J, Matyas BT et al. Capacity of state and territorial health agencies to prevent foodborne illness. Emerging Infectious Diseases 2005;11(1):11-16.
Jacoby D, St Louis T, Navarro V. Hepatitis C practice routines among Connecticut’s naturopathic physicians. American Journal of Gastroenterology 2001;96(9):2801-2802.
Jones JL, Ogunmodede F, Scheftel J et al. Toxoplasmosis-related knowledge and practices among pregnant women in the United States. Infectious Diseases in Obstetrics & Gynecology 2003;11(3):139-145.
Lillquist PP, Thomas N, Belay ED, Schonberger LB, Morse D. Barriers to autopsy: Creutzfeldt-Jakob disease in New York state. Neuroepidemiology 2006;26(4):207-211.
Louie JK, Gavali SS, Belay ED et al. Barriers to Creutzfeldt-Jakob disease autopsies, California. Emerg Infect Dis 2004;10(9):1677-1680.
Pinner RW. Addressing the challenges of emerging infectious disease. Am J Med Sci 1996; 311(1):3-8.
Pinner RW, Rebmann CA, Schuchat A, Hughes JM. Disease surveillance and the academic, clinical, and public health communities. Emerging Infectious Diseases 2003;9(7):781-787.
Stephens DS, Moxon ER, Adams J et al. Emerging and reemerging infectious diseases: a multidisciplinary perspective. Am J Med Sci 1998; 315(2):64-75.
Stricof RL, Lillquist PP, Thomas N, Belay ED, Schonberger LB, Morse DL. An investigation of potential neurosurgical transmission of Creutzfeldt-Jakob disease: challenges and lessons learned. Infection Control & Hospital Epidemiology 2006; 27(3):302-304.
Szilagyi PG, Shone LP, Barth R et al. Physician practices and attitudes regarding adult immunizations. Preventive Medicine 2005;40(2):152-161.
Townes JM, Hoffmann CJ, Kohn MA. Neurocysticercosis in Oregon, 1995-2000. Emerging Infectious Diseases 2004;10(3):508-510.
Virata M, Rosenstein NE, Hadler JL et al. Suspected Brazilian purpuric fever in a toddler with overwhelming Epstein-Barr virus infection. Clinical Infectious Diseases 1998; 27(5):1238-1240.
Williams LK, Reichert A, MacKenzie WR, Hightower AW, Blake PA. Lice, nits, and school policy. Pediatrics 2001;107(5):1011-1015.
- Page last reviewed: April 1, 2011
- Page last updated: April 1, 2011
- Content source: